Citation Impact
Citing Papers
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
2002 Standout
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
Long Non-Coding RNAs Control Hematopoietic Stem Cell Function
2015
UALCAN: An update to the integrated cancer data analysis platform
2022 Standout
An Interaction with Ewing’s Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer
2016
Effector Caspases and Leukemia
2011
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group
1993
Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients
2004
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
The molecular hallmarks of epigenetic control
2016 Standout
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
1998 Standout
The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP
1998
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Oncogenic kinase signalling
2001 StandoutNature
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1
1994
The 8p11 Myeloproliferative Syndrome: A Distinct Clinical Entity Caused by Constitutive Activation of <i>FGFR1</i>
2002
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
2008
Cellular signaling by fibroblast growth factor receptors
2005 Standout
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Richter syndrome
2004
Caspase Functions in Cell Death and Disease
2013 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Epigenetic protein families: a new frontier for drug discovery
2012
The essence of senescence: Figure 1.
2010 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis
1999
Reactive oxygen species in cancer
2010 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
8p11 myeloproliferative syndrome: a review
2010
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
MicroRNA signatures in human cancers
2006 Standout
Genetics of therapy-related myelodysplasia and acute myeloid leukemia
2008
ROS signalling in the biology of cancer
2017 Standout
Myeloproliferative Disorders with Translocations of Chromosome 5q31–35: Role of the Platelet-Derived Growth Factor Receptor Beta
2002
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Five years since the discovery of FIP1L1–PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias
2008
Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
1996
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
IgE, mast cells, basophils, and eosinophils
2010 Standout
Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: Study of nine cases
1996
The Fibroblast Growth Factor signaling pathway
2015 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Interferon-γ: an overview of signals, mechanisms and functions
2003 Standout
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features
2006
Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12;q12)
1998
Activation of FIP1L1-PDGFRα requires disruption of the juxtamembrane domain of PDGFRα and is FIP1L1-independent
2006
Cancer Cell Cycles
1996 StandoutScience
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Molecular analysis of cutaneous B- and T-cell lymphomas
1995
Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes
1999 StandoutNobel
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction
2010
Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia
2011
Detailed Molecular Delineation of 13q14.3 Loss in B-Cell Chronic Lymphocytic Leukemia
1998
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia
1996
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
2000 StandoutScience
Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)
2010
Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
1998 Standout
Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation
1992
Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia
1997
High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
1995
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
1999 Standout
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
Negative Regulation of Cytokine Signaling Pathways
2000 Standout
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features
2009
11q Deletions Identify a New Subset of B-Cell Chronic Lymphocytic Leukemia Characterized by Extensive Nodal Involvement and Inferior Prognosis
1997
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Therapy-Related Acute Leukemia
2000
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy Trials
1997
t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia
2000
Works of C Mecucci being referenced
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice
2008
Trisomy 3 is a consistent chromosome change in malignant lymphoproliferative disorders preceded by cold agglutinin disease
1995
Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder
2007
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: impact on WHO classification
2006
Chromosome 11q rearrangements in B non Hodgkin's lymphoma
1992
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia
2005
B-cell non-Hodgkin's lymphomas of follicle mantle lineage: part of a biological spectrum?
1991
TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13)
1995
Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia.
2002
5q- anomaly in lymphoid disorders.
1990
Cytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemia.
1990
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.
2005
About the t(8;13)(p11;q12) clinico-pathologic entity [letter]
1996
Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria.
1995